QS Investors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-4,600
| Closed | -$126K | – | 1681 |
|
2019
Q4 | $126K | Hold |
4,600
| – | – | ﹤0.01% | 1321 |
|
2019
Q3 | $132K | Sell |
4,600
-26
| -0.6% | -$746 | ﹤0.01% | 1307 |
|
2019
Q2 | $129K | Hold |
4,626
| – | – | ﹤0.01% | 1330 |
|
2019
Q1 | $154K | Hold |
4,626
| – | – | ﹤0.01% | 1293 |
|
2018
Q4 | $135K | Buy |
4,626
+4,600
| +17,692% | +$134K | ﹤0.01% | 1247 |
|
2018
Q3 | $1K | Hold |
26
| – | – | ﹤0.01% | 1795 |
|
2018
Q2 | $1K | Hold |
26
| – | – | ﹤0.01% | 1818 |
|
2018
Q1 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 1836 |
|
2017
Q4 | – | Sell |
-4,283
| Closed | -$155K | – | 2001 |
|
2017
Q3 | $155K | Sell |
4,283
-1,867
| -30% | -$67.6K | ﹤0.01% | 1320 |
|
2017
Q2 | $159K | Hold |
6,150
| – | – | ﹤0.01% | 1297 |
|
2017
Q1 | $118K | Hold |
6,150
| – | – | ﹤0.01% | 1367 |
|
2016
Q4 | $103K | Hold |
6,150
| – | – | ﹤0.01% | 1274 |
|
2016
Q3 | $127K | Hold |
6,150
| – | – | ﹤0.01% | 1209 |
|
2016
Q2 | $188K | Sell |
6,150
-15
| -0.2% | -$459 | ﹤0.01% | 1107 |
|
2016
Q1 | $231K | Buy |
6,165
+8
| +0.1% | +$300 | ﹤0.01% | 1054 |
|
2015
Q4 | $266K | Buy |
6,157
+7
| +0.1% | +$302 | ﹤0.01% | 1037 |
|
2015
Q3 | $231K | Sell |
6,150
-7,000
| -53% | -$263K | ﹤0.01% | 1041 |
|
2015
Q2 | $447K | Hold |
13,150
| – | – | 0.01% | 896 |
|
2015
Q1 | $466K | Sell |
13,150
-4,926
| -27% | -$175K | 0.01% | 890 |
|
2014
Q4 | $616K | Buy |
+18,076
| New | +$616K | 0.01% | 823 |
|
2014
Q3 | – | Sell |
-25,200
| Closed | -$981K | – | 777 |
|
2014
Q2 | $981K | Buy |
+25,200
| New | +$981K | 0.03% | 386 |
|
2013
Q4 | – | Sell |
-317,700
| Closed | -$7.47M | – | 609 |
|
2013
Q3 | $7.47M | Buy |
317,700
+255,700
| +412% | +$6.01M | 0.32% | 92 |
|
2013
Q2 | $1.67M | Buy |
+62,000
| New | +$1.67M | 0.06% | 308 |
|